An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase

OncoImmunology

Volumn 2, Issue 1, 2013, Pages

  Kwong, Christina ^a   Gilman Sachs, Alice ^a   Beaman, Kenneth ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cancer related inflammation; CD14; CD16; IL 1; Pro inflammatory monocytes; Tumor associated macrophages; Vacuolar ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CD14 ANTIGEN; CD16 ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR INTERACTION; MONOCYTE; PHARMACOLOGICAL BLOCKING; PHENOTYPIC VARIATION; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR MICROENVIRONMENT;

EID: 84886944488     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22978     Document Type: Article

References (52)

1. Sennoune SR, Luo D, Martínez-Zaguilán R. Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys 2004; 40:185-206; http://dx.doi.org/10.1385/ CBB:40:2:185.
2. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 1993; 265:C1015-29
3. Kubota S, Seyama Y. Overexpression of vacuolar ATPase 16-kDa subunit in 10T1/2 fibroblasts enhances invasion with concomitant induction of matrix metalloproteinase-2. Biochem Biophys Res Commun 2000; 278:390-4; http://dx.doi. org/10.1006/bbrc.2000.3802.
4. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66:6699-707; http://dx.doi.org/10.1158/0008-5472.CAN-06-0983.
5. Sennoune SR, Bakunts K, Martínez GM, Chua-Tuan JL, Kebir Y, Attaya MN, et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 2004; 286:C1443-52; http://dx.doi.org/10.1152/ajpcell. 00407.2003.
6. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; http://dx.doi.org/10.1016/S1471-4906(02)02302-5.
7. Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, et al. Origins of tumorassociated macrophages and neutrophils. Proc Natl Acad Sci U S A 2012; 109:2491-6; http://dx.doi.org/10.1073/pnas.1113744109.
8. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287-92; http://dx.doi.org/10.1084/ jem.176.1.287.
9. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10:137-42; http:// dx.doi.org/10.1016/S1074-7613(00)80014-X.
10. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64:7022-9; http://dx.doi.org/10.1158/0008-5472.CAN-04-1449.
11. Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res 2005; 65:10637-41; http://dx.doi.org/10.1158/0008-5472.CAN-05-3473.
12. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4:583-94; http://dx.doi.org/10.1038/nri1412.
13. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-86; http:// dx.doi.org/10.1016/j.it.2004.09.015.
14. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74-80; http://dx.doi.org/10.1182/blood-2010-02-258558.
15. Almeida J, Bueno C, Algueró MC, Sanchez ML, de Santiago M, Escribano L, et al. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLADR(+)/ CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells. Clin Immunol 2001; 100:325-38; http://dx.doi.org/10.1006/clim.2001.5072
16. Kwong C, Gilman-Sachs A, Beaman K. Tumorassociated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing protumorigenic properties in monocytes. J Immunol 2011; 186:1781-9; http://dx.doi. org/10.4049/jimmunol.1002998.
17. Ntrivalas E, Gilman-Sachs A, Kwak-Kim J, Beaman K. The N-terminus domain of the a2 isoform of vacuolar ATPase can regulate interleukin-1beta production from mononuclear cells in co-culture with JEG-3 choriocarcinoma cells. Am J Reprod Immunol 2007; 57:201-9; http://dx.doi.org/10.1111/j.1600-0897.2006.00463.x.
18. Ntrivalas E, Derks R, Gilman-Sachs A, Kwak-Kim J, Levine R, Beaman K. Novel role for the N-terminus domain of the a2 isoform of vacuolar ATPase in interleukin-1beta production. Hum Immunol 2007; 68:469-77; http://dx.doi. org/10.1016/j.humimm.2007.02.010.
19. Gürsoy RN, Siahaan TJ. Binding and internalization of an ICAM-1 peptide by the surface receptors of T cells. J Pept Res 1999; 53:414-21; http:// dx.doi.org/10.1034/j.1399-3011.1999.00079.x.
20. Apodaca G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic 2001; 2:149-59; http:// dx.doi.org/10.1034/j.1600-0854.2001.020301.x.
21. Newman SL, Mikus LK, Tucci MA. Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptormediated phagocytosis. J Immunol 1991; 146:967-74;
22. Allen LA, Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med 1996; 184:627-37; http:// dx.doi.org/10.1084/jem.184.2.627.
23. Gekle M, Mildenberger S, Freudinger R, Schwerdt G, Silbernagl S. Albumin endocytosis in OK cells: dependence on actin and microtubules and regulation by protein kinases. Am J Physiol 1997; 272:F668-77;
24. Piasek A, Thyberg J. Effects of colchicine on endocytosis of horseradish peroxidase by rat peritoneal macrophages. J Cell Sci 1980; 45:59-71;
25. Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118:e16-31; http://dx.doi.org/10.1182/ blood-2010-12-326355.
26. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem 2009; 78:857-902; http://dx.doi.org/10.1146/annurev. biochem.78.081307.110540.
27. Araki N, Johnson MT, Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996; 135:1249-60; http://dx.doi. org/10.1083/jcb.135.5.1249.
28. Areschoug T, Gordon S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol 2009; 11:1160-9; http:// dx.doi.org/10.1111/j.1462-5822.2009.01326.x.
29. Sulahian TH, Imrich A, Deloid G, Winkler AR, Kobzik L. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res 2008; 9:59; http://dx.doi.org/10.1186/1465-9921-9-59.
30. Yao W, Li K, Liao K. Macropinocytosis contributes to the macrophage foam cell formation in RAW264.7 cells. Acta Biochim Biophys Sin (Shanghai) 2009; 41:773-80; http://dx.doi. org/10.1093/abbs/gmp066.
31. Greenberg JW, Fischer W, Joiner KA. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect Immun 1996; 64:3318-25;
32. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A 1990; 87:9133-7; http://dx.doi. org/10.1073/pnas.87.23.9133.
33. Merkulova M, McKee M, Dip PV, Grüber G, Marshansky V. N-terminal domain of the V-ATPase a2-subunit displays integral membrane protein properties. Protein Sci 2010; 19:1850-62; http://dx.doi.org/10.1002/pro.470.
34. Steinbrecher UP, Lougheed M, Kwan WC, Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem 1989; 264:15216-23;
35. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct 1980; 13:67-81; http://dx.doi.org/10.1002/jss.400130107.
36. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, et al. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 1995; 230:408-15; http:// dx.doi.org/10.1111/j.1432-1033.1995.0408h.x.
37. Freeman MW. Scavenger receptors in atherosclerosis. Curr Opin Hematol 1997; 4:41-7; http://dx.doi.org/10.1097/00062752-199704010-00007.
38. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27:669-92; http://dx.doi.org/10.1146/ annurev.immunol.021908.132557.
39. Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 1996; 17:424-8; http://dx.doi.org/10.1016/0167-5699(96)10029-3.
40. Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol 2000; 67:603-6;
41. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168:3536-42;
42. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-92; http://dx.doi.org/10.1189/jlb.0806510.
43. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 2007; 28:519-24; http://dx.doi.org/10.1016/j.it.2007.09.004.
44. Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, et al. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol 2010; 161:471-9; http://dx.doi. org/10.1111/j.1365-2249.2010.04200.x.
45. Nishimura S, Takahashi S, Kamikatahira H, Kuroki Y, Jaalouk DE, O'Brien S, et al. Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J Biol Chem 2008; 283:11752-62; http://dx.doi.org/10.1074/jbc. M708849200.
46. Chaigne-Delalande B, Guidicelli G, Couzi L, Merville P, Mahfouf W, Bouchet S, et al. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol 2008; 181:7630-8;
47. Inoue Y, Tanaka N, Tanaka Y, Inoue S, Morita K, Zhuang M, et al. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol 2007; 81:8722-9; http:// dx.doi.org/10.1128/JVI.00253-07.
48. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006; 10:839-50; http://dx.doi.org/10.1016/j.devcel. 2006.04.002.
49. Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J Virol 2009; 83:4895-911; http:// dx.doi.org/10.1128/JVI.02498-08.
50. Burgdorf S, Kautz A, Böhnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007; 316:612-6; http://dx.doi. org/10.1126/science.1137971.
51. Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 2004; 173:1166-70;
52. Kindzelskii AL, Huang JB, Chaiworapongsa T, Fahmy RM, Kim YM, Romero R, et al. Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils. J Clin Invest 2002; 110:1801-11